- Stroke Prevention in Atrial Fibrillation: Managing the Risks in Light of New Oral Anticoagulants. Strobeck, John // Cardiovascular Drugs & Therapy;Aug2012, Vol. 26 Issue 4, p331
Anticoagulation in patients with atrial fibrillation is essential to reduce morbidity and mortality associated with stroke, but at the same time the risk of bleeding needs to be carefully considered. There have been many recent developments in anticoagulation to improve medical management of...
- Demystifying anticoagulation in primary care. Fitzmaurice, David; Gold, Lorna // Pulse;6/17/2002, Vol. 62 Issue 24, p64
Presents guidelines for physicians in prescribing oral anticoagulants to patients. Utilization of anticoagulation on patients with atrial fibrillation; Side effects of warfarin; Discussion of the monitoring of patients using anticoagulants.
- Warfarin. // Reactions Weekly;11/28/2009, Issue 1280, p45
The article describes the case of a 36-year-old man who acquired distension of the haematoma while undergoing anticoagulant therapy with warfarin. The patient experienced spontaneous splenic rupture (SSR) which developed after an intrasplenic infarction due to infection with Bacillus species....
- Ventricular assist devices and non-cardiac surgery. Roberts, S. Michael; Hovord, David G.; Sathishkumar, Subramanian; Kodavatiganti, Ramesh // BMC Anesthesiology;12/19/2015, p1
The use of ventricular assist devices has expanded significantly since their approval by the Food and Drug Administration in the United States in 1994. In addition to this, the prevalence of heart failure continues to increase. We aim to provide an overview of perioperative considerations and...
- Extended anticoagulation reduces recurrent thrombotic events. // Geriatrics;Jun99, Vol. 54 Issue 6, p14
Focuses on the reduction of the risk for venous thromboembolisms through anticoagulant therapy. Adverse effects of the anticoagulant therapy; Significance of the optimum duration of the therapy; Safety of the warfarin therapy for older patients without contraindications.
- Apixaban and Dabigatran Found Effective, Safe for Extended Venous Thromboembolism Therapy. Moon, Mary Ann // Neurology Reviews;Apr2013, Vol. 21 Issue 4, p26
The article provides information related to three clinical trials published in the periodical "New England Journal of Medicine" on February 21, 2013, which states that anticoagulants apixaban and dabigatran are effective for extended treatment of venous thromboembolism. It mentions that apixaban...
- Anticoagulant prescription more common in AF patients, underused in elderly. Byrne, Jen; Costa, Samantha; Swain, Erik; Taliercio, Adam; Volansky, Rob // Cardiology Today;Apr2014, Vol. 17 Issue 4, p55
The article reports that prescription of anticoagulants are more common in atrial fibrillation (AF) patients, but are less used among older people due to concerns of bleeding risk, which was concluded by a study on 3.119 patients with AF enrolled between February 2012 and March 2013.
- Dabigatran etexilate. // Reactions Weekly;6/30/2012, Issue 1408, p13
The article describes the case of a 66-year-old woman with renal insufficiency who experienced gastrointestinal bleeding after undergoing dabigatran etexilate therapy for atrial fibrillation.
- Aspirin/clopidogrel/dabigatran etexilate. // Reactions Weekly;1/5/2013, Issue 1433, p10
The article describes several cases of patients who experienced haemorrhagic disorders while undergoing dabigatran-etexilate, aspirin and clopidogrel therapy.